Pfizer Down Nearly 6%, on Track for Largest Percent Decline in Over a Decade

Pfizer Inc. (PFE) is currently at $39.03, down $2.42 or 5.83%

— Would be lowest close since April 22, 2019, when it closed at $38.98

— On pace for largest percent decrease since Jan. 26, 2009, when it fell 10.32%

— Earlier Tuesday, both Morgan Stanley and Bank of America downgraded their rating for Pfizer, Benzinga reported

— On Monday, Pfizer Inc. said it had agreed to merge its off-patent drugs business with Mylan N.V., creating a new company that will be one of the world’s biggest sellers of lower-priced medicines in an increasingly competitive market

— Currently down four of the past five days

— Currently down two consecutive days; down 9.41% over this period

— Worst two day stretch since the two days ending Nov. 20, 2008, when it fell 11.3%

— Down 9.89% month-to-date

— Down 10.57% year-to-date

— Down 22% from its all-time closing high of $50.04 on April 12, 1999

— Traded as low as $38.82; lowest intraday level since April 22, 2019, when it hit $38.81

— Down 6.34% at today’s intraday low; largest intraday percent decrease since Feb. 5, 2018, when it fell as much as 7.13%

— Worst performer in the DJIA today

— Eighth worst performer in the S&P 500 today

— Most active stock in the S&P 500 today

— Subtracted 16.41 points from the DJIA so far today

All data as of 10:44:57 AM

https://www.marketscreener.com/PFIZER-23365019/news/Pfizer-Down-Nearly-6-on-Track-for-Largest-Percent-Decrease-in-Over-a-Decade-Data-Talk-28982433/